Clinical Trials Directory

Trials / Completed

CompletedNCT01150539

Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome

Effects of Physical Activity on Insulin Resistance and Adiposity in Polycystic Ovary Syndrome "Poly"

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

The effects of a 16-week exercise training program on insulin resistance and adiposity in overweight/obese women with Polycystic ovary syndrome (PCOS).

Detailed description

Young, overweight/obese women with PCOS along with age and BMI-matched healthy controls without PCOS will be enrolled in this study. Participants will have assessments of body composition (by DEXA), visceral and ectopic fat (by MR), ovarian parameters (follicle size and number, by MRI) insulin sensitivity (by euglycemic hyperinsulinemic clamp), interstitial lipolysis (by microdialysis), whole body lipolysis and glycolysis (by stable isotopes), aerobic fitness (by VO2max test) and a fat biopsy performed across two clinic visits (1 outpatient visit, and 1 overnight stay). Participants in the control group will undergo these assessments once only, whereas participants in the PCOS Group will have these assessments twice, once at baseline and once following a 16 week supervised aerobic exercise program. Throughout the exercise program body weight will be measured weekly and menstrual cycle frequency will be documented on a calendar. Additionally, vital signs, weight, waist and hip circumferences will be measured and a fasting blood sample collected every 4 weeks.

Conditions

Interventions

TypeNameDescription
OTHER16-week exercise training programThe primary objective of the study is to investigate the effects of a 16-week exercise training program on insulin resistance and adiposity in overweight/obese women with PCOS.
OTHERControl Group without PCOSA group of overweight/obese women without PCOS will be enrolled as a control group and will be studied only once at baseline to allow for comparisons between the two study populations.

Timeline

Start date
2007-01-01
Primary completion
2007-05-01
Completion
2007-06-01
First posted
2010-06-25
Last updated
2021-08-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01150539. Inclusion in this directory is not an endorsement.